Huʻi vs. Chronic Hepatitis C: Ka hoʻomaopopo ʻana i kāu koho koho

Anter

• Nā hana no ka maʻi hepatitis C
• Nā hana no ka maʻi hepatitis C mau
• Ka hoʻoliʻiliʻi ate
• E kamaʻilio me kāu kauka

ʻO ka Hepatitis C kahi maʻi e pili ana i ke ake. Ke noho nei me ka hepatitis C no ka manawa lōʻihi hiki ke hōʻino i kou ake a hiki i kahi e holo pono ʻole ai. Hiki i ka mālama mua ʻana ke pale aku i kou ake a mālama i kou ola.

Hoʻokaʻawale nā ​​kauka i ka hepatitis C i ʻelua mau ʻano e pili ana i ka lōʻihi o kou loaʻa ʻana i kēia ʻano.

• ʻO ka hepatitis C ākea ka pae mua ke loaʻa ʻoe i ka maʻi hepitis ma lalo o ʻeono mau mahina.
• ʻO ka hepatitis C maʻi lōʻihi ka lōʻihi lōʻihi, ʻo ia hoʻi ua loaʻa ʻoe i ke ʻano no ʻeono mau mahina. Hiki i nā poʻe i loaʻa i ka maʻi hepitis C e hoʻomōhala i ke ʻano mau o ka maʻi.

Paipai kāu kauka i kahi lāʻau lapaʻau e pili ana i ke ʻano o ka hepatitis C i loaʻa iā ʻoe. ʻO ka hoʻomaopopo ʻana i kāu koho koho e kōkua iā ʻoe e hoʻoholo pono.

Nā hana no ka maʻi hepatitis C

Inā loaʻa iā ʻoe ka hepatitis C huehue, ʻaʻole pono ʻoe e mālama koke iā ia. I ka poʻe me kēia maʻi, e hoʻomaʻemaʻe iā ia iho me ka ʻole o ka lāʻau.

Pono ʻoe e kiaʻi ʻia. E hāʻawi aku kāu kauka iā ʻoe i kahi hōʻoia koko HCV RNA i kēlā me kēia ʻehā a i ʻewalu mau pule ma kahi o ʻeono mahina. Hōʻike kēia hōʻike i ka nui o ka maʻi hepatitis C (HCV) i kou kahe koko.

I kēia manawa, hiki iā ʻoe ke hoʻoili i ka maʻi i nā poʻe ʻē aʻe ma o ka pili ʻana o ke koko a ke koko. Hōʻalo i ka kaʻana like ʻana a hoʻohana hou paha paha i nā nila. ʻO kahi laʻana, pili kēia i ke kiʻi ʻana i ka peʻa a i ʻole ke kī ʻana i kahi hoʻonohonoho ʻole ʻia, a i ʻole nā ​​lāʻau hoʻomoʻa. I ka wā o ka moekolohe, e hoʻohana i kahi condom a i ʻole kahi hana pale pale pale e pale ai i ka lawe ʻana i ka maʻi i nā poʻe ʻē aʻe.

Inā holoi ka maʻi i ʻeono mau mahina, ʻaʻole pono ʻoe e mālama ʻia. Akā he mea nui e makaʻala i pale i ka loaʻa hou ʻana o ka maʻi i ka wā e hiki mai ana.

Nā hana no ka maʻi hepatitis C mau

ʻO kahi hōʻoia koko HCV RNA maikaʻi ma hope o ʻeono mau mahina ke ʻano he maʻi hepatitis C mau kou. Pono ʻoe i ka lapaʻau e pale ai i ka maʻi mai ka hōʻino ʻana i kou ake.

Hoʻohana ka lapaʻau nui i nā lāʻau antiviral e hoʻomaʻemaʻe i ka maʻi mai kou kahe koko. Hiki i nā lāʻau antiviral hou ke hoola i nā mea hou aku ma mua o ka poʻe me ka maʻi hepa hepatitis C.

E koho kāu kauka i kahi lāʻau antiviral a i ʻole ka hui pū ʻana o nā lāʻau e pili ana i ka nui o ka hōʻino o ke ake āu, he aha nā ʻano maʻi āu i hana ai i ka wā i hala, a he aha ka hepatitis C genotype i loaʻa iā ʻoe. ʻEono mau genotypes. Pane kēlā me kēia genotype i kekahi mau lāʻau.

ʻO nā lāʻau Antiviral i ʻae ʻia e FDA e mālama i ka maʻi hepitis C āpau:

• daclatasvir / sofosbuvir (Daklinza) - nā genotypes 1 a me 3
• elbasvir / grazoprevir (Zepatier) - genotypes 1 a me 4
• glecaprevir / pibrentasvir (Mavyret) - nā genotypes 1, 2, 5, 6
• ledipasvir / sofosburir (Harvoni) - genotypes 1, 4, 5, 6
• ombitasvir / paritaprevir / ritonavir (Technivie) - genotype 4
• ombitasvir / paritaprevir / ritonavir and dasabuvir (Viekira Pak) - genotypes 1a, 1b
• simeprevir (Olysio) - genotype 1
• sofosbuvir / velpatasvir (Epclusa) - nā genotypes āpau
• sofosbuvir (Sovaldi) - nā genotypes āpau
• sofosbuvir / velpatasvir / voxilaprevir (Vosevi) - nā genotypes āpau

ʻO Peginterferon alfa-2a (Pegasys), peginterferon alfa-2b (Pegintron), a me ribavirin (Copegus, Rebetol, Ribasphere) i mau maʻa maʻamau no ka maʻi hepitis C. maʻi mau, akā lōʻihi lākou i ka hana ʻana a ʻaʻole pinepine hoola i ka mea hoʻomaʻi. Hoʻokumu pū lākou i nā hopena ʻē aʻe e like me ke kuni, ke anuanu, ka nalo ʻana o ka makemake, a me ka ʻāʻī ʻeha.

I kēia lā, hoʻohana pinepine ʻia nā peginterferon alfa a me ribavirin no ka mea ʻoi aku ka maikaʻi o nā lāʻau antiviral hou a hoʻonui i nā hopena ʻē aʻe. Akā ʻo ka hui pū ʻana o peginterferon alfa, ribavirin, a me sofosbuvir ka lapaʻau maʻamau no nā poʻe me nā genotypes hepatitis C 1 a me 4.

E lawe ʻoe i nā lāʻau hepitis no 8 a 12 mau pule. I ka wā o ka mālama ʻana, e hāʻawi kāu kauka iā ʻoe i nā hoʻokolohua koko manawa e ana i ka nui o ka maʻi hepitis C i waiho ʻia i kou kahena koko.

ʻO ka pahuhopu ka loaʻa ʻole o kahi maʻi o ka maʻi i loko o kou koko ma ka liʻiliʻi he 12 mau pule ma hope o kou hoʻopau ʻana i ka lāʻau. Kapa ʻia kēia he pane virologic hoʻomau ʻia, a i ʻole SVR. ʻO ka manaʻo ia ua kūleʻa kāu lapaʻau ʻana.

Inā holo ʻole ka lapaʻau mua āu e hoʻāʻo ai, hiki i kāu kauka ke kuhikuhi iā ʻoe i ka lāʻau ʻokoʻa i loaʻa nā hopena maikaʻi aʻe.

Ka hoʻoliʻiliʻi ate

Hōʻino ka Hepatitis C a hoʻoweliweli i ke ake. Inā ʻoe i noho me ka maʻi no nā makahiki he nui, hiki i kou ate ke hōʻino ʻia a hiki i kahi e hana hou ʻole ai. I kēlā manawa, koi paha kāu kauka i kahi neʻe ʻana o ke ake.

Lawe ke kuʻi akepaʻa i kou ake akea a hoʻololi iā ia me kahi mea olakino hou. ʻO ka manawa pinepine ke akepaʻa mai kahi mea hāʻawi i make, akā hiki ke hoʻololi ʻia nā mea hāʻawi ola.

ʻO ke kiʻi ʻana i kahi ake hou e kōkua iā ʻoe e hōʻoluʻolu, akā ʻaʻole ia e hoʻōla i kāu maʻi hepatita C. E hana ai i ka hoʻōla ʻana i ka maʻi a loaʻa iā SVR, pono ʻoe e ʻai i ka lāʻau antiviral e kūlike i kāu genotype maʻi.

E kamaʻilio me kāu kauka

I kēia lā, kōkua nā lāʻau antiviral hou e hōʻola i nā poʻe hou aku me ka maʻi hepitis C ma mua o nā makahiki i hala. Inā loaʻa iā ʻoe ka maʻi hepitis C a i ʻole makaʻu paha ia, e ʻike pono i kāu kauka. Hiki iā lākou ke hoʻāʻo iā ʻoe no ka maʻi maʻi a hoʻoholo i ke ʻano o ka maʻi hepitis C i loaʻa iā ʻoe. Inā makemake ʻoe i ka lāʻau, hiki i kāu kauka ke kōkua iā ʻoe e hana i kahi hoʻolālā lapaʻau no ka mālama ʻana i ka hepatitis C a me ka hana ʻana i kahi lāʻau.